Anti-LILRB1 Reference Antibody (D2M Biotherapeutics patent anti-LILRB1), IgG1, Monoclonal

Produktübersicht

• Artikelname: Anti-LILRB1 Reference Antibody (D2M Biotherapeutics patent anti-LILRB1), IgG1, Monoclonal
• Artikelnummer: SYB-CHB899
• Hersteller Artikelnummer: CHB899
• Alternativnummer: SYB-CHB899-100UG, SYB-CHB899-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-LILRB1 Reference Antibody (D2M Biotherapeutics patent anti-LILRB1)(CHB899) is expressed from CHO. The heavy chain type is IgG1, and the light chain type is kappa. It has a predicted MW of 146.22 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• Isotyp: IgG1
• UniProt: Q8NHL6
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: LILRB1 / ILT2 / CD85j